Evidence map›Paper›PMID 37443138›Full record

ArticleBMC research notes2023

A quick, easy and efficient protocol for extracting high-quality RNA from Mycobacterium tuberculosis using a spin column commercial kit.

N E Mvubu, A Salig, K Moopanar, Asg Nyide, D Govender, E Mankayi

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

N E MvubuMedical Microbiology, School of Laboratory Medicine and Medical Sciences, College of Health Science, Medical School, University of KwaZulu Natal, Private Bag X54001, Durban, 4000, South Africa. Mvubun@ukzn.ac.za.
A SaligMicrobiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu Natal, Durban, South Africa.
K MoopanarMicrobiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu Natal, Durban, South Africa.
Asg NyideMicrobiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu Natal, Durban, South Africa.
D GovenderMicrobiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu Natal, Durban, South Africa.
E MankayiMicrobiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu Natal, Durban, South Africa.
University of KwaZulu-Natal · ZA

Funding

European and Developing Countries Clinical Trials Partnership TMA2020CDF-3167National Research Foundation 129635
6 · The paper itself

Abstract

RNA extraction from Mycobacterium tuberculosis has been a historically challenging task for researchers due to the thick lipids associated with the cell wall of this "notorious" pathogen that is responsible for Tuberculosis (TB) outbreaks. Several studies have successfully extracted RNA from M. tuberculosis using a Trizol reagent combined with organic solvents. Recently, our laboratory has successfully extracted high quality total RNA using a commercial kit from clinical strains belonging to F15/LAM4/KZN, Beijing and F11 strain families and H37Rv laboratory strain by exploiting high speed homogenizer for cell lysis and spin columns for RNA purification. The quality and integrity of the extracted RNA was analyzed and confirmed through the Nanodrop, Bioanalyzer and RNA 3-(N-morpholino) propanesulfonic acid (MOPS) gel electrophoresis. Furthermore, to confirm the integrity of small RNA (sRNA) molecules due to their vulnerability to degradation, the RNA samples were converted to cDNA and sRNAs were amplified and confirmed through PCR. This detailed RNA extraction protocol proposes to carve a new path into TB transcriptome research without the use of organic solvent for downstream purification steps while yielding high quality RNA that can be used to understand M. tuberculosis transcriptome regulation.

Indexed as

Mycobacterium tuberculosisTuberculosisBeijingHumansPolymerase Chain ReactionRNARNACommercial kitM. tuberculosisProtocolRNA extraction

Identifiers

PMID37443138
PMCPMC10347756
OpenAlexW4384155154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.